Table 3.

Adverse events.

	Patients (n=26)
Treatment-related AEs, n (%)	Grade I-II	Grade III
Fatigue	14 (53.8)	0
Pruritus	11 (42.3)	0
Radiation Proctitis	10 (38.5)	0
Nausea	8 (30.8)	0
Leukopenia	8 (30.8)	0
Rash	7 (26.9)	0
Diarrhea	7 (26.9)	0
Anemia	6 (23.1)	0
Abdominal pain	5 (19.2)	0
Neutropenia	4 (15.4)	0
Arthralgia	2 (7.7)	0
Alanine transaminase increased	2 (7.7)	0
Chest pain	1 (3.8)	0
Hyperthyroidism	1 (3.8)	0
Hypothyroidism	1 (3.8)	0
Skin depigmentation	1 (3.8)	0
Bullous pemphigoid	1 (3.8)	0
Immune checkpoint inhibitor-associated colitis	0	1 (3.8)
Immune-related AEs, n (%)
Immune checkpoint inhibitor-associated colitis	0	1 (3.8)
Hyperthyroidism	1 (3.8)	0
Hypothyroidism	1 (3.8)	0
Skin depigmentation	1 (3.8)	0
Bullous pemphigoid	1 (3.8)	0